Sorry, you need to enable JavaScript to visit this website.

Sign Up For Mailing List Button

Donate to Genetic Alliance

Disease Search Button

APPENDIX A. Federal Regulations

Facebook icon
Twitter icon
LinkedIn icon
  1. 32 CFR 219: Protection of Human participants (the Common Rule)
  2. 45 CFR 46: Subpart B: Additional Protections Pertaining to Research, Development, and Related Activities Involving Fetuses, Pregnant Women, and Human In Vitro Fertilization; Subpart C: Additional      Protections Pertaining to Biomedical and Behavioral Research Involving Prisoners as Participants; and Subpart D: Additional Protections for Children involved as Participants in Research
  3. 21 CFR 50: Protection of Human participants (FDA)
  4. 21CFR 54: Financial Disclosures by Clinical Investigators (FDA)
  5. 21 CFR 56: Institutional Review Boards (FDA)
  6. 21 CFR 312: Investigational New Drug (IND) Application (FDA)
  7. 21 CFR 812: Investigational Device Exemption (IDE) (FDA)
  8. 45 CFR 160 & 164: Health Insurance Portability and Accountability Act (HIPAA) of 1996 (

Follow Us

Twitter icon
Facebook icon
LinkedIn icon
YouTube icon

4301 Connecticut Ave NW, Suite 404, Washington DC 20008-2369 | Tel: 202.966.5557 | Fax: 202.966.8553 | EIN 52-1571905

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 3.0 License.